Boston, United States
Newpath is a private venture capital investment fund focused on disruptive treatments and technologies in the life science space. We search for innovative approaches across diverse fields including but not limited to: pharmaceuticals, regenerative and personalized medicine, basic sciences, devices, drug discovery, cellular and gene therapies, robotics, AR/VR and AI. With each investment, Newpath seeks to optimize performance by aligning the interests of academic founders, management teams, and investor groups.
8
Total Investments
8
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Newpath Partners
Recent Investments (8)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Early VC | •••••• | Apr 2024 | |
| Series A | •••••• | Sep 2023 | |
| Series A | •••••• | May 2023 | |
| Series B | •••••• | Mar 2023 | |
| Series B | •••••• | Oct 2022 | |
•••• ••••
|
Seed | •••••• | Sep 2022 |
|
•••• ••••
|
Series B | •••••• | Oct 2021 |
|
•••• ••••
|
Series A | •••••• | Jun 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
